HER2-Positive Breast Cancer

Get a quick, expert overview of clinically-focused topics and guidelines that are relevant to testing for HER2, which contributes to approximately 25% of breast cancers today. This concise resource by Drs. Sara Hurvitz, and Kelly McCann consolidates today''s available information on this growing topic into one convenient resource, making it an ideal, easy-to-digest reference for practicing and trainee oncologists.- Covers the diagnosis, treatments and targeted therapies, and management of breast cancers that are HER2-positive.- Contains sections on background and testing, advanced disease, therapeutics, and toxicity considerations.- Includes a timely section on innovative future therapies.